Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

AstraZeneca’s Breztri Aerosphere Finally Receives FDA Approval for COPD and Will Later Address Unmet Need in Asthma

AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) was finally approved in the US for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Credit: Chinnapong via Shutterstock.


Go Top